A new trading day began on Friday, with Olema Pharmaceuticals Inc (NASDAQ: OLMA) stock price up 5.35% from the previous day of trading, before settling in for the closing price of $5.79. OLMA’s price has ranged from $5.56 to $16.77 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -7.49%. With a float of $42.88 million, this company’s outstanding shares have now reached $57.29 million.
In an organization with 74 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 85.67%, operating margin of -7213.69%, and the pretax margin is -6511.62%.
Olema Pharmaceuticals Inc (OLMA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Olema Pharmaceuticals Inc is 25.14%, while institutional ownership is 84.98%. The most recent insider transaction that took place on Dec 17 ’24, was worth 4,730,137. In this transaction Director of this company sold 700,761 shares at a rate of $6.75, taking the stock ownership to the 0 shares. Before that another transaction happened on Dec 13 ’24, when Company’s Affiliate proposed sale 700,761 for $6.75, making the entire transaction worth $4,730,137.
Olema Pharmaceuticals Inc (OLMA) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.62 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -7.49% per share during the next fiscal year.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Here are Olema Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.19, a number that is poised to hit -0.64 in the next quarter and is forecasted to reach -2.65 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Let’s dig in a bit further. During the last 5-days, its volume was 1.39 million. That was better than the volume of 0.77 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 7.20%. Additionally, its Average True Range was 0.81.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 4.92%, which indicates a significant decrease from 10.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 111.08% in the past 14 days, which was higher than the 78.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.20, while its 200-day Moving Average is $11.40. However, in the short run, Olema Pharmaceuticals Inc’s stock first resistance to watch stands at $6.31. Second resistance stands at $6.52. The third major resistance level sits at $6.83. If the price goes on to break the first support level at $5.79, it is likely to go to the next support level at $5.48. The third support level lies at $5.27 if the price breaches the second support level.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
With a market capitalization of 368.23 million, the company has a total of 57,298K Shares Outstanding. Currently, annual sales are 0 K while annual income is -96,660 K. The company’s previous quarter sales were 0 K while its latest quarter income was -34,560 K.
